Metropolitan Life Insurance Company (MetLife)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,554
Closed -$299K 2593
2021
Q4
$299K Buy
3,554
+12
+0.3% +$1.01K ﹤0.01% 1742
2021
Q3
$319K Sell
3,542
-119
-3% -$10.7K ﹤0.01% 1730
2021
Q2
$349K Sell
3,661
-13,329
-78% -$1.27M ﹤0.01% 1754
2021
Q1
$1.93M Sell
16,990
-590
-3% -$67.2K 0.03% 532
2020
Q4
$2.43M Buy
17,580
+1,059
+6% +$147K 0.04% 400
2020
Q3
$1.36M Sell
16,521
-713
-4% -$58.6K 0.02% 588
2020
Q2
$1.35M Buy
17,234
+646
+4% +$50.5K 0.02% 574
2020
Q1
$737K Sell
16,588
-711
-4% -$31.6K 0.02% 831
2019
Q4
$739K Sell
17,299
-399
-2% -$17K 0.01% 1093
2019
Q3
$757K Buy
17,698
+807
+5% +$34.5K 0.01% 1026
2019
Q2
$1.07M Buy
16,891
+238
+1% +$15.1K 0.02% 854
2019
Q1
$1.16M Buy
16,653
+1,268
+8% +$87.9K 0.02% 810
2018
Q4
$669K Buy
15,385
+198
+1% +$8.61K 0.01% 1028
2018
Q3
$1.16M Hold
15,187
0.02% 854
2018
Q2
$1.17M Buy
15,187
+1,037
+7% +$79.7K 0.02% 844
2018
Q1
$722K Buy
14,150
+1,481
+12% +$75.5K 0.01% 1060
2017
Q4
$588K Sell
12,669
-13,804
-52% -$641K 0.01% 1175
2017
Q3
$1.41M Hold
26,473
0.01% 1075
2017
Q2
$1.64M Hold
26,473
0.01% 1015
2017
Q1
$1.79M Buy
26,473
+1,299
+5% +$88K 0.01% 985
2016
Q4
$1.77M Sell
25,174
-425
-2% -$29.9K 0.01% 1017
2016
Q3
$1.82M Sell
25,599
-2,148
-8% -$152K 0.01% 987
2016
Q2
$1.36M Hold
27,747
0.01% 1092
2016
Q1
$1.76M Buy
27,747
+1,243
+5% +$78.7K 0.01% 936
2015
Q4
$2.97M Hold
26,504
0.02% 742
2015
Q3
$2.55M Buy
26,504
+1,528
+6% +$147K 0.02% 807
2015
Q2
$2.56M Buy
+24,976
New +$2.56M 0.02% 860
2015
Q1
Sell
-5,748
Closed -$252K 2389
2014
Q4
$252K Hold
5,748
﹤0.01% 2241
2014
Q3
$325K Sell
5,748
-1,511
-21% -$85.4K ﹤0.01% 2018
2014
Q2
$326K Sell
7,259
-222
-3% -$9.97K ﹤0.01% 2138
2014
Q1
$366K Buy
+7,481
New +$366K ﹤0.01% 2021